SEMPER PARATUS ACQU -CW26 (TVGNW) Stock News

NASDAQ:TVGNW -

0.0601 USD

0 (0%)

Last: 8/22/2025, 8:00:02 PM

Technical Analysis

TVGNW Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma

a day ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Recognized in BINJE’s BEST Health Care 2025 for Advancing Health Equity and Sustainable Biopharma

4 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

4 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts

4 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

4 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum

5 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

5 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

5 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

5 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

9 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected

9 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen to Release Internal Asset Valuation; CEO Affirms Assets Are Fully Protected

10 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

10 days ago - By: Tevogen Bio Inc - Mentions: TVGN MSFT

Repeat - Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio Reaffirms Investor Confidence with Estimated Asset Value Exceeding $10 Billion

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT -- Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio Oncology Reports Top-Line Revenue Forecast of $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $10 Billion and $14 Billion; Forecasts for Non-Oncology Therapeutic Areas to Follow

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

12 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT - Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

15 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

15 days ago - By: Tevogen Bio Inc - Mentions: TVGN

REPEAT - Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

16 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy

16 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Receives $1 Million to Accelerate AI-Driven Drug Discovery; Remains Well Capitalized to Execute Growth Strategy

17 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

17 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Sees Significant Institutional Ownership Growth; 73% of Holders Increase Positions

18 days ago - By: Tevogen Bio Inc - Mentions: TVGN MSFT

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

18 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology

22 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

22 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen CEO Affirms Strong Growth, Capital Position, and AI Expansion in Letter to Stockholders

22 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

22 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Bio to Accept $1 Million Additional Grant Funding for AI Expansion

24 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

24 days ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen Highlights 74% Insider Ownership, Reinforcing Long-Term Vision

a month ago - By: Tevogen Bio Inc - Mentions: TVGN MSFT

Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare

a month ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen.AI Applauds U.S. Government’s AI Action Plan; Reaffirms Commitment to Accelerating AI Innovation in Healthcare

a month ago - By: Tevogen Bio Inc - Mentions: TVGN MSFT

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides

a month ago - By: Tevogen Bio Inc - Mentions: TVGN

Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides